# Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

Study · id `cardio:ct-nct03417388` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03417388](<https://clinicaltrials.gov/study/NCT03417388>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT03417388

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 2476 participants.

## Technical summary

Registry record NCT03417388. Randomized; single masking; primary purpose treatment. Start 2018-02-09 (actual); primary completion 2025-02-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 2476 participants (enrolled count; ClinicalTrials.gov record NCT03417388, source copy `cardio:ctgov-nct03417388-2026-11-18`, retrieved 2026-11-18)
- Started: 2018-02-09 (actual) (ClinicalTrials.gov record NCT03417388, source copy `cardio:ctgov-nct03417388-2026-11-18`, retrieved 2026-11-18)
- Primary completion: 2025-02-15 (actual) (ClinicalTrials.gov record NCT03417388, source copy `cardio:ctgov-nct03417388-2026-11-18`, retrieved 2026-11-18)
- Completion: 2027-04-16 (anticipated) (ClinicalTrials.gov record NCT03417388, source copy `cardio:ctgov-nct03417388-2026-11-18`, retrieved 2026-11-18)
- Countries: United States; Puerto Rico (ClinicalTrials.gov record NCT03417388, source copy `cardio:ctgov-nct03417388-2026-11-18`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03417388-2026-11-18`, retrieved 2026-11-18)

## The registry's words

- Brief title: Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
- Acronym: WARRIOR
- Condition: Coronary Artery Disease
- Intervention (Drug): High dose potent statin
- Intervention (Drug): ACE-I (lisinopril) or ARB (losartan)
- Intervention (Drug): Aspirin 81 enteric coated tablet daily
- Intervention (Behavioral): Lifestyle Counseling
- Intervention (Behavioral): Quality of Life Questionnaires
- Lead sponsor: Cedars-Sinai Medical Center
- Lead sponsor class: OTHER
- Collaborator: United States Department of Defense
- Collaborator class: FED
- Collaborator: University of Florida
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Cedars-Sinai Medical Center (`cardio:org-cedars-sinai-medical-center`)
- Registry lists this organization as a collaborator: University of Florida (`cardio:org-university-of-florida`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (WARRIOR): a randomised controlled trial (`cardio:pubmed-41932694`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: deafbe2ae4072bebaf781a8a134152b72b0abb5794493de92616cf5658c54351
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
